Clinical Care Options HIV - Toward Timely Treatment: Risks of and Strategies to Address Delayed Antiretroviral Therapy

Expert Roundtable on the Risks of and Strategies to Address Delayed Antiretroviral Therapy

Faculty:

Keith Henry, MD
Kenneth A. Lichtenstein, MD
Kimberly Y. Smith, MD, MPH

CREDIT INFORMATION

Release Date: January 22, 2009

Expiration Date: January 21, 2010

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.4 Nursing contact hours

Status: The activity is not currently available for credit.

Watch CME/CE-certified video of an expert faculty panel discussing recent changes to treatment guidelines on when to initiate antiretroviral therapy as well as other issues affecting the timely treatment of HIV, including HIV testing and connecting HIV-infected patients to care.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss potential obstacles to routine opt-out HIV testing
Recount current guidelines on initiation of antiretroviral therapy
Explain the clinical risks associated with initiation of antiretroviral therapy later than is currently recommended
Debate the potential advantages and disadvantages of initiating antiretroviral therapy in all HIV-infected patients

Module

Toward Timely Treatment: Risks of and Strategies to Address Delayed Antiretroviral Therapy

Faculty:

Keith Henry, MD

CREDIT INFORMATION

Release Date: January 22, 2009

Expiration Date: January 21, 2010

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.2 Nursing contact hours

Status: The activity is not currently available for credit.

Keith Henry, MD, discusses guidelines regarding when to initiate antiretroviral therapy in treatment-naive patients and offers practical suggestions on how to promote earlier detection of HIV infections.

Learning Objectives

Upon completion of this activity, participants should be able to:

Specify current guidelines on routine opt-out HIV testing
Explain current guidelines on initiation of antiretroviral therapy
Discuss the clinical risks associated with initiation of antiretroviral therapy later than currently recommended
Debate the potential advantages and disadvantages of initiating antiretroviral therapy in all HIV-infected patients

Abstract

Click here to view abstract

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.